Symlin Amylin Pharmaceuticals, Inc. - Treatment for Diabetes in conjunction with insulin
Symlin is a synthetic analog of human amylin, a naturally occurring hormone that is made in the beta cells of the pancreas. Symlin is used in conjunction with insulin to control glucose in patients with type 2 diabetes who use insulin, and in patients with type 1 diabetes.Posted: March 2005
Related articles
- FDA Approves Symlin Pen-Injector Devices Offering Convenience andAccuracy for Symlin Use - October 1, 2007
- Amylin Pharmaceuticals Submits Complete Response to FDA for Symlin - September 30, 2004
Symlin (pramlintide acetate) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
